SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-322615
Filing Date
2019-12-23
Accepted
2019-12-23 16:14:03
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A d772939ds1a.htm S-1/A 2481901
2 EX-10.10 d772939dex1010.htm EX-10.10 405832
3 EX-23.1 d772939dex231.htm EX-23.1 1952
4 GRAPHIC g772939g02j14.jpg GRAPHIC 110183
5 GRAPHIC g772939g12h25.jpg GRAPHIC 59374
6 GRAPHIC g772939g26k67.jpg GRAPHIC 61928
7 GRAPHIC g772939g26n37.jpg GRAPHIC 63542
8 GRAPHIC g772939g56a10.jpg GRAPHIC 89079
9 GRAPHIC g772939g63b02.jpg GRAPHIC 73046
10 GRAPHIC g772939g67g12.jpg GRAPHIC 75965
11 GRAPHIC g772939g75s93.jpg GRAPHIC 126302
12 GRAPHIC g772939g78b06.jpg GRAPHIC 165251
13 GRAPHIC g772939g88v15.jpg GRAPHIC 150912
14 GRAPHIC g772939g94q83.jpg GRAPHIC 216613
  Complete submission text file 0001193125-19-322615.txt   4532829
Mailing Address 200 STATE STREET BOSTON MA 02109
Business Address 200 STATE STREET BOSTON MA 02109 (617) 837-6911
Centrexion Therapeutics Corp (Filer) CIK: 0001592052 (see all company filings)

IRS No.: 320402377 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-227902 | Film No.: 191306166
SIC: 2834 Pharmaceutical Preparations